Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease
Most people start noticing an improvement in energy levels within 2-3 weeks
Epithalon is investigated as a Khavinson-class short peptide with proposed epigenetic regulatory activity, including studies reporting telomerase reactivation, telomere elongation in cell-culture models, and modulation of melatonin and serotonin biosynthesis in the pineal gland
Issue: Ophthalmologist unfamiliar or disapproving Common scenario: Most conventional ophthalmologists unfamiliar with peptide research, view as unproven experimental treatment, may discourage use out of caution or lack of knowledge
Prohibition of this kind tends to produce silence rather than data
Mitochondria as central hub of the immune system